Sir, Autologous hematopoietic stem cell transplant (HSCT) for Crohn's disease (CD) has been described by Oyama and co-workers as achieving remission in 11 out of 12 patients with refractory CD after a median follow-up of 18.5 months.1 They postulated that autologous HSCT was useful for refractory CD. We wish to report a case of a 32-year-old female patient with biopsy-proven CD diagnosed when she was 16 years old. ...please note that changes to the previously submitted letter have been underlined in the main body of text...
- Crohn's disease
- Stem cell